Research
Metabolic adaptation
Lifestyle modification remains the cornerstone of MASLD/MASH management alongside semaglutide.
Practitioners should emphasize lifestyle changes in addition to pharmacotherapy for optimal management.
StrongSupportsmedium confidence
Lifestyle modification remains the cornerstone of MASLD/MASH management alongside semaglutide.
Why this rating
Based on expert consensus and practice guidance.
Source
Semaglutide therapy for metabolic dysfunction–associated steatohepatitis: November 2025 updates to AASLD Practice Guidance
Meena B. Bansal et al. · Hepatology · 2025
otherCited 32×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →